The effects of postoperative radiotherapy on survival outcomes in patients under 65 with estrogen receptor positive tubular breast carcinoma

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011;378(9804):1707–1716.

Cooper HS, Patchefsky AS, Krall RA. Tubular carcinoma of the breast. Cancer. 1978;42(5):2334–42.

McDivitt RW, Boyce W, Gersell D. Tubular carcinoma of the breast. Clinical and pathological observations concerning 135 cases. Am J Surg Pathol. 1982;6(5):401–11.

Leibman AJ, Lewis M, Kruse B. Tubular carcinoma of the breast: mammographic appearance. AJR Am J Roentgenol. 1993;160(2):263–5.

Rosen PP. Tubular carcinoma. In: Rosen’s breast pathology. Philadelphia, PA: Lippincott-Raven; 1996. p. 325–6.

Wasif N, McCullough AE, Gray RJ, Pockaj BA. Influence of uncommon histology on breast conservation therapy for breast cancer-biology dictates technique? J Surg Oncol. 2012;105(6):586–90.

Rakha EA, Lee AH, Evans AJ, Menon S, Assad NY, Hodi Z, et al. Tubular carcinoma of the breast: further evidence to support its excellent prognosis. J Clin Oncol. 2010;28(1):99–104.

Livi L, Paiar F, Meldolesi E, Talamonti C, Simontacchi G, Detti B, et al. Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients. Eur J Surg Oncol. 2005;31(1):9–12.

Lea V, Gluch L, Kennedy CW, Carmalt H, Gillett D. Tubular carcinoma of the breast: axillary involvement and prognostic factors. ANZ J Surg. 2015;85(6):448–51.

Min Y, Bae SY, Lee HC, Lee JH, Kim M, Kim J, et al. Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ. J Breast Cancer. 2013;16(4):404–9.

Liu GF, Yang Q, Haffty BG, Moran MS. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2009;75(5):1304–8.

Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, et al. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg. 2007;194(4):527–31.

Kitchen PR, Smith TH, Henderson MA, Goldhirsch A, Castiglione-Gertsch M, Coates AS, et al. Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapy. ANZ J Surg. 2001;71(1):27–31.

Wu SG, Zhang WW, Sun JY, Li FY, Chen YX, He ZY. Omission of postoperative radiotherapy in women aged 65 years or older with tubular carcinoma of the breast after breast-conserving surgery. Front Oncol. 2018;8:190.

Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol. 1999;17:1442–8.

Hansen CJ, Kenny L, Lakhani SR, Ung O, Keller J, Tripcony L, et al. Tubular breast carcinoma: an argument against treatment de-escalation. J Med Imaging Radiat Oncol. 2012;56(1):116–22.

Kunkler IH, Williams LJ, Jack WJ, Cameron DA. Dixon JM; PRIME II investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015;16(3):266–73.

Cho WK, Choi DH, Lee J, Park W, Kim YB, Suh CO, et al. Comparison of failure patterns between tubular breast carcinoma and invasive ductal carcinoma (KROG 14-25). Breast. 2018;38:165–70.

Fritz P, Bendrat K, Sonnenberg M, Trautmann C, Ott G, Heidemann E, et al. Tubular breast cancer. A retrospective study. Anticancer Res. 2014;34(7):3647–56.

Li B, Chen M, Nori D, Chao KS, Chen AM, Chen SL. Adjuvant radiation therapy and survival for pure tubular breast carcinoma--experience from the SEER database. Int J Radiat Oncol Biol Phys. 2012;84(1):23–9.

Sullivan T, Raad RA, Goldberg S, Assaad SI, Gadd M, Smith BL, Taghian AG, et al. Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat. 2005;93(3):199–205.

Surveillance, Epidemiology, and End Results (SEER) Program ( www.seer.cancer.gov ) SEER*Stat Database: Incidence - SEER 18 Regs Custom Data (with chemotherapy recode), Nov 2015 Sub (2000–2013) <Katrina/Rita Population Adjustment> − Linked To County Attributes - Total U.S., 1969–2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released July 2016, based on the November 2015 submission.

Vinh-Hung V, Voordeckers M, Van de Steene J, Soete G, Lamote J, Storme G. Omission of radiotherapy after breast-conserving surgery: survival impact and time trends. Radiother Oncol. 2003;67(2):147–58.

Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351(10):971–7.

Tinterri C, Gatzemeier W, Zanini V, Regolo L, Pedrazzoli C, Rondini E, et al. Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: a prospective randomised multicentre trial. Breast. 2009;18(6):373–7.

Colleoni M, Rotmensz N, Maisonneuve P, Mastropasqua MG, Luini A, Veronesi P, et al. Outcome of special types of luminal breast cancer. Ann Oncol. 2012;23(6):1428–36.

McBoyle MF, Razek HA, Carter JL, Helmer SD. Tubular carcinoma of the breast: an institutional review. Am Surg. 1997;63(7):639–44.

Jayasekera J, Schechter CB, Sparano JA, Jagsi R, White J, Chapman JW, et al. Effects of radiotherapy in early-stage, low-recurrence risk, hormone-sensitive breast Cancer. J Natl Cancer Inst. 2018. https://doi.org/10.1093/jnci/djy128 . Epub ahead of print.

Mamounas EP, Tang G, Fisher B, Paik S, Shak S, Costantino JP, et al. Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol. 2010;28(10):1677–83.

Holland DW, Boucher LD, Mortimer JE. Tubular breast cancer experience at Washington University: a review of the literature. Clin Breast Cancer. 2001;2(3):210–4.

Cabral AH, Recine M, Paramo JC, McPhee MM, Poppiti R, Mesko TW. Tubular carcinoma of the breast: an institutional experience and review of the literature. Breast J. 2003;9(4):298–301.

Noone AM, Lund JL, Mariotto A, Cronin K, McNeel T, Deapen D, et al. Comparison of SEER treatment data with Medicare claims. Med Care. 2016;54(9):e55–64.

Jagsi R, Abrahamse P, Hawley ST, Graff JJ, Hamilton AS, Katz SJ. Underascertainment of radiotherapy receipt in surveillance, epidemiology, and end results registry data. Cancer. 2012;118(2):333–41.